
VERACYTE INC
VCYTNASDAQ🏆 #1446 by market capEarnings Nov 3US Equity
$45.53▼ $0.87 (−1.90%)
Live1h▼ 0.7%
24h▼ 1.9%
7d▼ 1.2%
14d▼ 18.3%
30d▼ 20.8%
1y▲ 58.3%
🏦Market Cap
$3.63B
Small Cap
📈Revenue Growth (YoY)
+16.0%
Healthy
📊Gross Margin
72.1%
High
💵FCF Margin
29.4%
Strong
⚖️P/S Ratio
6.6x
Fair
Otter Score
51
Weak
📊
Analyst Ratings
Price
$45.53
Total
21
Raised
0
Lowered
4
Avg PT
$55.57
H / L
$69 / $44
| Institution | Action | Rating | Date |
|---|---|---|---|
Needham | Reiterated | Buy | 2026-07-31 |
Piper Sandler | Reiterated | Overweight | 2026-07-15 |
Canaccord Genuity | Reiterated | Hold | 2026-07-14 |
Morgan Stanley | Reiterated | Underweight | 2026-07-09 |
Guggenheim | Reiterated | Buy | 2026-06-29 |
UBS | Reiterated | Buy | 2026-05-06 |
Stephens & Co. | Reiterated | Overweight | 2025-03-26 |
Goldman Sachs | Downgraded | Buy → Neutral | 2024-12-05 |
Scotiabank | Reiterated | Sector Outperform | 2024-11-08 |
Leerink Partners | Reiterated | Outperform | 2024-10-17 |
Raymond James | Downgraded | Outperform → Market Perform | 2023-01-18 |
SVB Leerink | Reiterated | Outperform | 2022-11-03 |
Truist Securities | Reiterated | Buy | 2021-05-18 |
KeyBanc | Reiterated | Sector Weight → Equal Weight | 2020-11-10 |
BTIG | Reiterated | Buy | 2020-11-04 |
Lake Street | Reiterated | Buy | 2019-07-31 |
Janney Montgomery Scott | Downgraded | Buy → Neutral | 2018-11-29 |
Janney Capital | Downgraded | Buy → Neutral | 2018-11-29 |
Leerink Swann | Reiterated | Outperform | 2017-11-07 |
BTIG Research | Reiterated | Buy | 2015-04-06 |
PiperJaffray | Reiterated | Overweight | 2014-06-20 |
One row per institution, most recent rating